The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity

被引：65

作者：

Aslan, Hatice Esra ^{[1
]}

Demir, Yeliz ^{[1
]}

ozaslan, Muhammet Serhat ^{[1
]}

Turkan, Fikret ^{[2
]}

Beydemir, Sukru ^{[3
]}

Kufrevioglu, Omer Irfan ^{[1
]}

机构：

[1] Ataturk Univ, Dept Chem, Fac Sci, Erzurum, Turkey

[2] Igdir Univ, Hlth Serv Vocat Sch, Igdir, Turkey

[3] Anadolu Univ, Dept Biochem, Fac Pharm, Eskisehir, Turkey

来源：

DRUG AND CHEMICAL TOXICOLOGY | 2019年 / 42卷 / 06期

关键词：

Acetylcholinesterase; carbonic anhydrase; chalcone; inhibition; purification;

D O I：

10.1080/01480545.2018.1463242

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Carbonic anhydrase (CA) has a key role in respiration, carbon dioxide and bicarbonate transport. Acetylcholinesterase (AChE) is a serine hydrolase and mostly abundant at neuromuscular junctions and cholinergic brain synapses. Inhibitors of these enzymes could aid in illuminating the role in disease processes. In this study, we separately purified CA I and CA II from human erythrocytes. The purity of the enzymes was showed by SDS-PAGE analysis. We also investigated the inhibition of seven chalcones toward hCA I, hCA II, and AChE. The chalcones were effective inhibitors of the cytosolic CA isoforms (hCA I and hCA II) and AChE with K-i values in the range of 1.83-7.05 mu M for hCA I, 0.59-5.50 mu M for hCA II, and 0.61-86.11 mu M for AChE. All compounds were showed competitive inhibition aganist both enzymes. These compounds can be a potent inhibitor of AChE enzyme and both cytosolic CA isoenzymes which are commonly used in the pharmaceutical and medical industries.

引用

页码：634 / 640

页数：7

共 51 条

[11]

Coskun D., Et al., Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: synthesis, characterization and anticancer activity, European Journal of Medicinal Chemistry, 136, pp. 212-222, (2017)

[12]

Dastan T., Et al., Investigation of acetylcholinesterase and mammalian DNA topoisomerases, carbonic anhydrase inhibition profiles, and cytotoxic activity of novel bis(alpha-aminoalkyl)phosphinic acid derivatives against human breast cancer, Journal of Biochemical and Molecular Toxicology, 31, 11, (2017)

[13]

Demir Y., Beydemir S., Purification, refolding, and characterization of recombinant human paraoxonase-1, Turkish Journal of Chemistry, 39, pp. 764-776, (2015)

[14]

Demir Y., Et al., Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney, Journal of Biochemical and Molecular Toxicology, 31, 9, (2017)

[15]

Demir Y., Oruc E., Topal A., Carbonic anhydrase activity responses and histopathological changes in gill and liver tissues after acute exposure to chromium in brown trout juveniles, Hacettepe Journal of Biology and Chemistry, 44, pp. 515-523, (2016)

[16]

Ekinci D., Beydemir S., Alim Z., Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II, Pharmacological Reports, 59, pp. 580-587, (2007)

[17]

El-Meligie S., Et al., Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds, European Journal of Medicinal Chemistry, 126, pp. 52-60, (2017)

[18]

Ellman G.L., Et al., A new and rapid colorimetric determination of acetylcholinesterase activity, Biochemical Pharmacology, 7, pp. 88-95, (1961)

[19]

Garibov E., Et al., Synthesis of 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I/II inhibitory and antioxidant activities, Journal of Enzyme Inhibition and Medicinal Chemistry, 31, pp. 1-9, (2016)

[20]

Genc H., Et al., Discovery of potent carbonic anhydrase and acetylcholinesterase inhibitors: 2-aminoindan beta-lactam derivatives, International Journal of Molecular Sciences, 17, 10, (2016)

← 1 2 3 4 5 6 →